Glucotrack, Inc. - 8-K Filing
Glucotrack filed an 8-K disclosing Lokahi Therapeutics' significant net loss of $8.1M in Q2 and substantial doubt about its ability to continue as a going concern.
Tickers: $GCTK
Glucotrack filed an 8-K disclosing Lokahi Therapeutics' significant net loss of $8.1M in Q2 and substantial doubt about its ability to continue as a going concern.
Tickers: $GCTK